tirzepatide surpass-5 Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes in Two Phase 3 Trials from Lilly's SURPASS Program-CliniExpert Zepbound Tirzepatide Injection 5 mg/0.5

In February 2024, Castor announced a partnership with Microsoft to utilize Azure and advanced AI technologies in their clinical trial platforms

And do not store the pen with the needle attached

Certain plans require prior authorization, which is how the insurance company confirms that a drug meets its criteria for coverage

We currently intend to use the net proceeds from this offering and the concurrent private placement, together with our existing cash and cash equivalents as follows: Based on our current operating plan, we believe that our existing cash and cash equivalents, together with the net proceeds from this offering, will be sufficient for us to fund our operations into 2029

Rose Hips Rose Hips fight skin pigmentation and speed up the healing process